Otrosdías's Avatar

Otrosdías

@otrosdias.bsky.social

For music go to: @otherdays.bsky.social For COVID, public health, politics, etc.. stay here...

740 Followers  |  1,480 Following  |  1,828 Posts  |  Joined: 28.09.2023
Posts Following

Posts by Otrosdías (@otrosdias.bsky.social)

Thanks, that's great!

02.03.2026 06:24 — 👍 1    🔁 0    💬 0    📌 0

Thanks, that's useful

02.03.2026 05:57 — 👍 1    🔁 0    💬 1    📌 0

As far as I understand, the increase in the proportion of asymptomatic infections is an assumption more than an empirical result in this study? (real question)

02.03.2026 05:47 — 👍 0    🔁 0    💬 1    📌 0

Excellent parenting

01.03.2026 15:37 — 👍 0    🔁 0    💬 0    📌 0
Preview
Progress for "Universal" Vaccine & More NextGen Covid Vax News (Update No 38) - Absolutely Maybe This month, there are phase 2 results for a self-amplifying mRNA vaccine from Japan—and that vaccine’s developers have recently completed a phase…

News-packed update on nextgen Covid vaccines this month at my @plos.org blog:

- Preclinical results for an intranasal "universal" vaccine that provided some protection from coronaviruses, H1N1 flu, some bacterial infections, and an asthma allergen... 1/2

absolutelymaybe.plos.org/2026/03/01/p...

01.03.2026 09:06 — 👍 32    🔁 17    💬 3    📌 0
Preview
Kombi-Impfung gegen Covid und Grippe | APOTHEKE ADHOC Die EU-Arzneimittelbehörde EMA hat grünes Licht gegeben für den ersten Kombi-Impfstoff gegen Corona und Grippe. Der Wirkstoff solle für Menschen ab 50 Jahren zugelassen werden, teilte die Behörde in A...

Die erste Kombi-Impfung gegen Covid und Grippe (auf mRNA-Basis) von Moderna für Menschen Ü50 steht kurz vor der Zulassung.

Die EMA hat bereits grünes Licht gegeben.

www.apotheke-adhoc.de/nachrichten/...

28.02.2026 18:18 — 👍 523    🔁 125    💬 16    📌 7

Correction: Newly released sequences from Northern Ireland 🇬🇧 indicate that the frequency of BA.3.2* remains high. This is noteworthy in light of recent posts by @gwladwr on X showing that BA.3.2* frequently targets children and that there is an uptick in COVID-19 cases among children. #BA32

28.02.2026 21:49 — 👍 8    🔁 3    💬 0    📌 1
Preview
Immune exhaustion, the culprit for long COVID and chronic complications Chronic immune exhaustions underlie the development of long COVID.

Virginia Tech researchers, 2 cohorts, found long COVID looks less like slow healing and more like an immune system stuck in overdrive with exhausted T cells and ongoing IL-6 JAK/STAT signaling, helping explain fatigue brain fog and breathlessness.

academic.oup.com/jleukbio/adv...

28.02.2026 19:36 — 👍 22    🔁 7    💬 1    📌 0

This is particularly important, because children are, by and large, not vaccinated in most countries at the moment. Therefore the conditions for them are much more like 2020 than for adults.

28.02.2026 17:51 — 👍 3    🔁 1    💬 0    📌 0

Italian!

28.02.2026 16:12 — 👍 0    🔁 0    💬 0    📌 0
Preview
ISLC-PAIS Conference 2026 in Amsterdam The ISLC-PAIS Conference brings together reseachers, clinicians and patient leaders working together to improve outcomes for people with Long COVID and other PAIS.

For those wanting the very best in Long C-19 Science‼️

💥 Registration opens very soon 💥

islc-pais.org

27.02.2026 23:09 — 👍 38    🔁 15    💬 0    📌 2

I’m sharing this not just as someone involved in campaigning, but as a mum.
At the start of the pandemic, I was told COVID wouldn’t affect children.My child developed #LongCovid.
That experience changes how you see everything, especially conversations about prevention.
@departmentforedu.bsky.social

27.02.2026 09:08 — 👍 27    🔁 13    💬 1    📌 0
Post image

Our paper on Symptom Patterns, Recovery, and Impact of
#LongCovid is now published. This is follow up data over 1 yr. Note how the pattern of symptoms changes over time with most starting out as fluctuating pattern and more ending up with a constant symptom pattern.
academic.oup.com/ofid/article...

27.02.2026 19:16 — 👍 85    🔁 34    💬 9    📌 6
Long COVID, ME/CFS, and other post-infectious diseases pose new questions for medicine and society. With the long-term data from the NAKO Health Study, Germany now aims to systematically clarify why some infections leave lasting effects and how those affected can be better supported.

Post-infectious diseases are on the rise. Infections such as COVID-19 can lead to chronic conditions such as Long COVID or ME/CFS months or even years later, affecting hundreds of thousands of people in Germany.
As part of the National Decade Against Post-Infectious Diseases, the Federal Ministry of Research, Technology, and Space (BMFTR) is investing approximately 500 million euros over the next decade to systematically research causes, disease mechanisms, diagnostics, and therapies and to improve care.
The NAKO Health Study, with 200,000 participants, provides crucial long-term data and enables a rare before-and-after comparison with data and biosamples from before, during, and after infection.
The aim of research is to determine the actual prevalence of post-infectious diseases more accurately, to better understand the underlying biological processes, and to effectively support those affected through targeted interventions in the future.

Long COVID, ME/CFS, and other post-infectious diseases pose new questions for medicine and society. With the long-term data from the NAKO Health Study, Germany now aims to systematically clarify why some infections leave lasting effects and how those affected can be better supported. Post-infectious diseases are on the rise. Infections such as COVID-19 can lead to chronic conditions such as Long COVID or ME/CFS months or even years later, affecting hundreds of thousands of people in Germany. As part of the National Decade Against Post-Infectious Diseases, the Federal Ministry of Research, Technology, and Space (BMFTR) is investing approximately 500 million euros over the next decade to systematically research causes, disease mechanisms, diagnostics, and therapies and to improve care. The NAKO Health Study, with 200,000 participants, provides crucial long-term data and enables a rare before-and-after comparison with data and biosamples from before, during, and after infection. The aim of research is to determine the actual prevalence of post-infectious diseases more accurately, to better understand the underlying biological processes, and to effectively support those affected through targeted interventions in the future.

Exciting to read about some of the expensive ME/CFS & long Covid research planned in Germany (using some of€500 million budget) including that using long-term samples which allow comparisons of samples before and after developing the conditions

www.helmholtz.de/en/newsroom/...

#LongCovid #MEcfs

27.02.2026 16:57 — 👍 31    🔁 14    💬 1    📌 0
Preview
Spain alerts WHO of swine flu virus believed to have been transmitted between people Spain has alerted the World Health Organization of what it believes to be a person-to-person transmission of the swine flu virus in its A(H1N1)v variant, a spokesperson for health authorities in the C...

Spain has alerted WHO of what it believes to be a person-to-person transmission of the swine flu virus in its A(H1N1)v variant
In a later statement, the Catalan health department said the risk assessment for the population was considered "very low". www.reuters.com/business/hea...

27.02.2026 15:05 — 👍 8    🔁 4    💬 0    📌 0

Interestingly, there seems to be an uptick in cases in France at the same time. This would be pretty atypical for BA.3.2, which has not led to waves elsewhere, but worth watching to see what happens. bsky.app/profile/dvdv...

27.02.2026 14:33 — 👍 3    🔁 0    💬 1    📌 0

So it doesn't look like Long COVID is a small problem that is going away.

26.02.2026 22:13 — 👍 4    🔁 0    💬 0    📌 0

That's incidence, whereas the Pulse survey is prevalence in the population. Either way, a 5-8% prevalence is massive and it was not falling for the last 12 months it was measured in the US, contrary to the initial claim.

26.02.2026 22:12 — 👍 4    🔁 0    💬 1    📌 0

" Contrary to assumptions of post-acute recovery, Long COVID is associated with progressively widening healthcare costs over five years (...) suggesting an evolving chronic disease burden with substantial and growing economic implications."

26.02.2026 17:50 — 👍 8    🔁 6    💬 0    📌 0
Preview
RFK Jr.'s CDC panel to discuss Covid vaccine injuries in upcoming meeting Past research has shown the Covid vaccines to be safe and effective.

RFK Jr.’s Advisory Committee on Immunization Practices will meet March 18-19 to discuss “COVID19 vaccine injuries”.

From what I’ve seen of this group, they will present poorly-controlled correlational data and anecdotes.

And they won’t publish these data beforehand in order to avoid scrutiny.

26.02.2026 14:05 — 👍 109    🔁 47    💬 7    📌 3
Preview
Five ways to spot when a paper is a fraud Science sleuths share their common-sense tips for sniffing out fishy articles.

important tools to help you spot fraudulent papers and Ai generated text

26.02.2026 13:23 — 👍 12    🔁 11    💬 0    📌 0
Major new report sets out how to tackle the ‘profound and lasting impact’ of Covid-19 on cardiovascular health

As a final skeet, let quote this recent report from the European Society of Cardiology: "Covid-19 has a profound and lasting impact on cardiovascular health, with complications emerging during acute illness, recovery, and even after reinfections or vaccination." www.escardio.org/news/press/p...

26.02.2026 13:22 — 👍 2    🔁 0    💬 0    📌 0

...since the end of the Pulse Survey, as, based on wastewater in 2025 the number of infections was lower than in 2024. But this is just a hypothesis and, of course, it can go up at any moment if cases go up again. So it's an issue that is very much alive and a public health emergency.

26.02.2026 13:22 — 👍 1    🔁 0    💬 1    📌 0

Basically, the prevalence of Long COVID will be given by the persistence in people who already have LC, the recovery rates and the new cases provoked by new infections. There is no current evience that this prevalence is actually falling. I would actually expect it to have fallen to some extent...

26.02.2026 13:22 — 👍 1    🔁 0    💬 1    📌 0

kidney problems, diabetes, dementia, etc...) the risk of which is proven to increase after an infection, but where the link may be missed by doctors treating the person. All of these are unlikely to be self-reported as Long COVID and so will be missing from the Pulse Survey.

26.02.2026 13:22 — 👍 2    🔁 0    💬 1    📌 0

Also, over time self-reporting may be more likely to underestimate LC rates, as testing reductions over this period means that people may increasingly have difficulties in linking their new symptoms to a specific infection. Finally, there are all of the well known sequelae (arrhythmias, strokes..

26.02.2026 13:22 — 👍 2    🔁 0    💬 1    📌 0

As to the differences between surveys, it all depends on the definition of Long COVID you use, if you include minor or major ailments, etc. Self-reported surveys could overstate LC (including people with LC being more likely to answer) or understate it (people with LC may be less able to respond).

26.02.2026 13:22 — 👍 0    🔁 0    💬 1    📌 0

Indeed, that was my point.

26.02.2026 13:08 — 👍 5    🔁 0    💬 2    📌 0

bsky.app/profile/otro...

26.02.2026 13:03 — 👍 5    🔁 0    💬 1    📌 0

bsky.app/profile/otro...

26.02.2026 13:03 — 👍 0    🔁 0    💬 0    📌 0